Milnacipran

Sort by

Dextro-milnacipran.HCl-D10

  • CAT Number DCTI-A-051
  • CAS Number 1217774-40-7
  • Molecular Formula C15H13D10ClN2O (HCl Salt) C15H12D10N2O (Free base)
  • Molecular Weight 292.87 (HCl Salt) 256.42 (Free base)

Levo-milnacipran.HCl – D10

  • CAT Number DCTI-A-114
  • CAS Number 175131-60-9(Unlabelled)
  • Molecular Formula C15H13D10ClN2O (HCl Salt) C15H12D10N2O (Free base)
  • Molecular Weight 292.87 (HCl Salt) 256.42 (Free bas)

General Information

Milnacipran Impurities and Milnacipran

Daicel Pharma offers the best-quality Milnacipran impurities and labeled standards. They are vital for evaluating Milnacipran quality, stability, and biological safety. Furthermore, Daicel Pharma specializes in the custom synthesis of Milnacipran impurities and ensures their worldwide delivery.

Milnacipran [CAS: 92623-85-3] belongs to a class of drugs, like serotonin and norepinephrine reuptake inhibitors (SNRIs). Levomilnacipran is the enantiomer of Milnacipran. It has fewer side effects compared to other tricyclic anti-depressants. It does not show neurological changes in the alpha1-adrenergic pathway.

Milnacipran: Use and Commercial Availability  

Milnacipran is a drug that treats patients with major depressive disorder (MDD) and fibromyalgia. It also treats pain disorders, including neuropathies. It improves fibromyalgia symptoms in patients. It is available as an oral formulation under Savella in the U.S. It is approved by the US FDA for the treatment of fibromyalgia. Milnacipran is sold globally under different brand names. In Japan, it is available as Toledomin and in Mexico, as Dalcipran.

Milnacipran Structure and Mechanism of ActionMilnacipran

The chemical name of Milnacipran is (1R,2S)-rel-2-(Aminomethyl)-N, N-diethyl-1-phenylcyclopropanecarboxamide. The chemical formula for Milnacipran is C15H22N2O, and its molecular weight is approximately 246.35 g/mol.

The precise mechanism of action of Milnacipran is unclear.

Milnacipran Impurities and Synthesis

Impurity formation during the synthesis of Milnacipran1 may affect the drug’s safety and efficacy. These impurities form during the manufacturing process, purification, or storage of Milnacipran. Therefore, Milnacipran impurities must be controlled and monitored throughout the drug’s development.
Daicel Pharma offers a comprehensive Certificate of Analysis (CoA) for Milnacipran impurities and labeled standards. We provide the CoA from a cGMP-compliant analytical facility. It gives complete characterization data2 such as 1H NMR, 13C NMR, IR, MASS, and HPLC purity. We provide additional analytical data on request. Daicel Pharma can prepare any unidentified Milnacipran impurity or degradation product. In addition, Daicel Pharma offers highly purified, stable isotope-labeled standards, such as Dextro-milnacipran.HCl-D10, and Levo-milnacipran.HCl–D10. We provide a complete characterization report to clients on delivery.

References
FAQ's

References

  1. Hascoet, Pierre; Cousse, Henri, Industrial process for producing Midalcipran, FR2581060B1, Apr 25, 1985, P. F. Medicament, France (https://www.lens.org/lens/search/patent/list?q=FR2581060A1)
  2. Puozzo, Christian; Filaquier, Christian; Zorza, Gregoire, Determination of milnacipran, a serotonin and noradrenaline reuptake inhibitor, in human plasma using liquid chromatography with spectrofluorimetric detection, Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, Volume: 806, Issue: 2, Pages: 221-228, 2004 DOI: (10.1016/j.jchromb.2004.03.063)

Frequently Asked Questions

IR, LC-MS, 1H NMR, and 13C NMR are the analytical methods that characterize Milnacipran impurities.

Contaminated raw materials, reagents, and unreacted catalysts during synthesis form process-related Milnacipran impurities.

Milnacipran impurities can affect drug safety and quality and pose health risks, so it is necessary to remove them from the drug.

Note: Products protected by valid patents by a manufacturer are not offered for sale in countries having patent protection. The sale of such products constitutes a patent infringement, and its liability is at the buyer's risk.

Back to Top
Product has been added to your cart